WASHINGTON — The pharmaceutical industry deployed its top guns to Capitol Hill on Wednesday as senators pushed to find consensus on a major package of drug pricing reforms.
Spotted in the Senate basement at lunchtime: Stephen Ubl, the head of the industry lobbying organization PhRMA, and Dr. Giovanni Caforio, the CEO of Bristol Myers-Squibb.
Their appearances were well-timed. Earlier Wednesday, Republicans lawmakers were briefed by the Congressional Budget Office on a drug pricing bill still under development in the Senate Finance Committee. Democrats were scheduled to receive the same briefing on Wednesday afternoon.
